Compound I is the reactive intermediate in the first monooxygenation step during conversion of cholesterol to pregnenolone by cytochrome P450scc: EPR/ENDOR/cryoreduction/annealing studies

J Am Chem Soc. 2012 Oct 17;134(41):17149-56. doi: 10.1021/ja3067226. Epub 2012 Oct 5.

Abstract

Cytochrome P450scc (CYP11A1) catalyzes conversion of cholesterol (CH) to pregnenolone, the precursor to all steroid hormones. This process proceeds via three sequential monooxygenation reactions: two stereospecific hydroxylations with formation first of 22R-hydroxycholesterol (22-HC) and then 20α,22R-dihydroxycholesterol (20,22-DHC), followed by C20-C22 bond cleavage. Herein we have employed EPR and ENDOR spectroscopy to characterize the intermediates in the first hydroxylation step by 77 K radiolytic one-electron cryoreduction and subsequent annealing of the ternary oxy-cytochrome P450scc-cholesterol complex. This approach is fully validated by the demonstration that the cryoreduced ternary complex of oxy-P450scc-CH is catalytically competent and hydroxylates cholesterol to form 22-HC with no detectable formation of 20-HC, just as occurs under physiological conditions. Cryoreduction of the ternary complex trapped at 77 K produces predominantly the hydroperoxy-ferriheme P450scc intermediate, along with a minor fraction of peroxo-ferriheme intermediate that converts into a new hydroperoxo-ferriheme species at 145 K. This behavior reveals that the distal pocket of the parent oxy-P450scc-cholesterol complex exhibits an efficient proton delivery network, with an ordered water molecule H-bonded to the distal oxygen of the dioxygen ligand. During annealing of the hydroperoxy-ferric P450scc intermediates at 185 K, they convert to the primary product complex in which CH has been converted to 22-HC. In this process, the hydroperoxy-ferric intermediate decays with a large solvent kinetic isotope effect, as expected when proton delivery to the terminal O leads to formation of Compound I (Cpd I). (1)H ENDOR measurements of the primary product formed in deuterated solvent show that the heme Fe(III) is coordinated to the 22R-O(1)H of 22-HC, where the (1)H is derived from substrate and exchanges to D after annealing at higher temperatures. These observations establish that Cpd I is the agent that hydroxylates CH, rather than the hydroperoxy-ferric heme.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Cholesterol / chemistry
  • Cholesterol / metabolism*
  • Cholesterol Side-Chain Cleavage Enzyme / chemistry
  • Cholesterol Side-Chain Cleavage Enzyme / metabolism*
  • Electron Spin Resonance Spectroscopy
  • Ferric Compounds / chemistry
  • Ferric Compounds / metabolism*
  • Ferrous Compounds / chemistry
  • Ferrous Compounds / metabolism*
  • Models, Molecular
  • Oxidation-Reduction
  • Oxygen / chemistry
  • Oxygen / metabolism*
  • Pregnenolone / chemistry
  • Pregnenolone / metabolism*

Substances

  • Ferric Compounds
  • Ferrous Compounds
  • Pregnenolone
  • Cholesterol
  • Cholesterol Side-Chain Cleavage Enzyme
  • Oxygen